ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,860.00
0.49%
S&P ASX All Technology
3,102.60
0.47%
Brent Oil
79.395
0.00%
US Dollar vs AUD
1.51653
0.00%
Bitcoin
69,296.01
-0.02%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. Danaher Corporation (DHR)

  7. Danaher Corporation (DHR) News

DHR

Danaher (DHR)

Danaher Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:DHR
DateTimeSourceHeadlineSymbolCompany
05/06/202421:00PR Newswire (US)Danaher Appoints Martin Stumpe to New Role of Chief Data & Artificial Intelligence OfficerNYSE:DHRDanaher Corporation
09/05/202421:00PR Newswire (US)Danaher Launches Collaboration with Johns Hopkins University Aiming to Improve Neurological DiagnosisNYSE:DHRDanaher Corporation
08/05/202406:45PR Newswire (US)Danaher to Present at Bank of America Securities Healthcare ConferenceNYSE:DHRDanaher Corporation
08/05/202406:15PR Newswire (US)Danaher Announces Quarterly DividendNYSE:DHRDanaher Corporation
03/05/202423:06PR Newswire (US)Curiox Biosystems and Beckman Coulter Life Sciences Announce a Partnership Combining C-FREE™ Technology with DURA Innovations for Hands-Free Washed Sample Preparation for Flow CytometryNYSE:DHRDanaher Corporation
23/04/202420:00PR Newswire (US)Danaher Reports First Quarter 2024 ResultsNYSE:DHRDanaher Corporation
22/03/202407:15PR Newswire (US)Danaher Schedules First Quarter 2024 Earnings Conference CallNYSE:DHRDanaher Corporation
28/02/202408:15PR Newswire (US)Danaher to Present at TD Cowen Health Care ConferenceNYSE:DHRDanaher Corporation
23/02/202408:15PR Newswire (US)Danaher Commits to Set Science-Based, Net-Zero Greenhouse Gas Emission Reduction TargetsNYSE:DHRDanaher Corporation
22/02/202408:15PR Newswire (US)Danaher Announces Quarterly DividendNYSE:DHRDanaher Corporation
05/02/202423:30PR Newswire (US)Danaher Launches Collaboration with Cincinnati Children's Hospital Medical Center Aiming to Improve Patient Safety in Early Drug DevelopmentNYSE:DHRDanaher Corporation
30/01/202422:00PR Newswire (US)Danaher Reports Fourth Quarter and Full Year 2023 ResultsNYSE:DHRDanaher Corporation
09/01/202423:30PR Newswire (US)Danaher, Jennifer Doudna, and Innovative Genomics Institute Launch Danaher-IGI Beacon for CRISPR Cures with Aim to Address Hundreds of Diseases Using Gene-editing Platform SolutionNYSE:DHRDanaher Corporation
09/01/202408:57Dow Jones NewsDanaher Says 4Q Adjusted. Revenue to Fall by Less Than ForecastNYSE:DHRDanaher Corporation
09/01/202408:15PR Newswire (US)Danaher CEO to Comment on Financial PerformanceNYSE:DHRDanaher Corporation
03/01/202409:00PR Newswire (US)Danaher to Present at J.P. Morgan Healthcare ConferenceNYSE:DHRDanaher Corporation
22/12/202308:30PR Newswire (US)Danaher Schedules Fourth Quarter 2023 Earnings Conference CallNYSE:DHRDanaher Corporation
14/12/202308:06GlobeNewswire Inc.Codexis and Aldevron Enter Exclusive Licensing Agreement for Codex® HiCap RNA PolymeraseNYSE:DHRDanaher Corporation
06/12/202323:30PR Newswire (US)Danaher Completes Acquisition of AbcamNYSE:DHRDanaher Corporation
06/12/202309:14Dow Jones NewsDanaher Cuts Quarterly Dividend to 24 CentsNYSE:DHRDanaher Corporation
06/12/202308:30PR Newswire (US)Danaher Announces Quarterly DividendNYSE:DHRDanaher Corporation
22/11/202308:15PR Newswire (US)Danaher to Present at Evercore ISI HealthCONx ConferenceNYSE:DHRDanaher Corporation
22/11/202306:22Dow Jones NewsDanaher on Track for Largest Percent Increase in Almost a Year -- Data TalkNYSE:DHRDanaher Corporation
31/10/202322:30PR Newswire (US)Danaher appoints Christopher Riley to Executive Vice President for BiotechnologyNYSE:DHRDanaher Corporation
24/10/202321:41Dow Jones NewsDanaher 3Q Earnings, Sales Decline but Beat EstimatesNYSE:DHRDanaher Corporation
24/10/202321:00PR Newswire (US)Danaher Reports Third Quarter 2023 ResultsNYSE:DHRDanaher Corporation
17/10/202321:34IH Market NewsKeep An Eye Out: Pre-Market Movers And Analyst RecommendationsNYSE:DHRDanaher Corporation
30/09/202322:00PR Newswire (US)Danaher Corporation Completes Separation of Veralto CorporationNYSE:DHRDanaher Corporation
29/09/202308:17PR Newswire (US)Veralto Set to Join S&P 500; Vestis to Join S&P MidCap 400; Others to Join S&P SmallCap 600NYSE:DHRDanaher Corporation
27/09/202306:15PR Newswire (US)Danaher Schedules Third Quarter 2023 Earnings Conference CallNYSE:DHRDanaher Corporation
 Showing the most relevant articles for your search:NYSE:DHR

Your Recent History

ASX
WPL
Woodside Petroleum
ASX
NAB
National Australia Bank
FX
AUDCAD
AUD vs CAD
PM
XAUUSD
Gold vs US Dollar
ASX
ANZ
Australia And New Zealan...
NASDAQ
NVDA
NVIDIA
ASX
XFL
S&P ASX 50
NASDAQ
AAPL
Apple
ASX
CBA
Commonwealth Bank Of Aus...
FX
GBPAUD
Sterling vs AUD
ASX
SUN
Suncorp
ASX
ORG
Origin Energy
ASX
RIO
Rio Tinto
NYSE
MCD
McDonalds
ASX
XJO
S&P ASX 200
NASDAQ
GOOGL
Alphabet
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved